Rocket
Premium
Excel Add-In
International
Tools
Dashboard
Screener
Spinoffs
IPOs
Register
Alerts
Sign In
Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Asset disposition
Quarterly results
Appointed director
Sage Therapeutics, Inc. (SAGE)
Create:
Alert
All
|
News
|
Filings
Date Filed
Type
Description
02/27/2019
424B5
Form 424B5 - Prospectus [Rule 424(b)(5)]:
02/25/2019
424B5
Form 424B5 - Prospectus [Rule 424(b)(5)]:
02/09/2018
424B5
Form 424B5 - Prospectus [Rule 424(b)(5)]:
02/07/2018
424B5
Form 424B5 - Prospectus [Rule 424(b)(5)]:
11/15/2017
424B5
Form 424B5 - Prospectus [Rule 424(b)(5)]:
11/13/2017
424B5
Form 424B5 - Prospectus [Rule 424(b)(5)]:
09/09/2016
424B5
Form 424B5 - Prospectus [Rule 424(b)(5)]
09/07/2016
424B5
Form 424B5 - Prospectus [Rule 424(b)(5)]
Rocket Data Systems, Inc. © 2019 |
Contact Us
|
Data Disclaimer
|
Terms of Use
|
Privacy